SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-137526
Filing Date
2021-11-12
Accepted
2021-11-12 08:00:56
Documents
12
Period of Report
2021-11-12
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132725d1_8k.htm   iXBRL 8-K 24497
  Complete submission text file 0001104659-21-137526.txt   199169

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coll-20211112.xsd EX-101.SCH 3210
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20211112_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20211112_pre.xml EX-101.PRE 22727
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2132725d1_8k_htm.xml XML 3636
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 211399701
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences